Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future

Constitutively activated prosurvival pathways render cancer cells addicted to their effects. Consequently they turn out to be the Achilles' heels whose inhibition can be exploited in anticancer therapy. Primary effusion lymphomas (PELs) are very aggressive non-Hodgkin's B cell lymphomas, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Granato, Marisa, Santarelli, Roberta, Gonnella, Roberta, Farina, Antonella, Trivedi, Pankaj, Faggioni, Alberto, Cirone, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324489/
https://www.ncbi.nlm.nih.gov/pubmed/25695042
http://dx.doi.org/10.1155/2015/104912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324489/
https://www.ncbi.nlm.nih.gov/pubmed/25695042
http://dx.doi.org/10.1155/2015/104912

Ejemplares similares